EyeGene Mutual Funds | StatInvestor

Health Care & Life Sciences » Biotechnology | EyeGene Inc.

EyeGene Inc. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

SPDR S&P World (ex-US) ETF

6,579

0.06%

09/06/2018

875

0.01%

875

0.2%

07/06/2018

View Profile

Address	Unit 910, Gangseo Han-gang Zai B Seoul SL 07528 Korea, Republic Of
Employees	-
Website	http://www.eyegene.co.kr
Updated	09/14/2018
Eyegene, Inc. engages in the research and development of pharmaceutical products. Its products include curing technologies and vaccines for diabetic retinopathy, decubitus ulcer, cervical cancer, and adjuvant immunotherapy. The company was founded on June 23, 2000 and is headquartered in Seoul, South Korea.